Tuesday 25 January 2022

Pfizer says third COVID shots may protect better against omicron

The U.S. pharma giant and its German partner BioNTech announced preliminary lab results showing a 25-fold increase in protection. Germany has ordered millions of booster doses as a new government takes over in Berlin.

Paying the bills

Latest

Government stops legalization of medical cannabis without daring to talk about a veto

QCOSTARICA - Legislators described the government's arguments for not...

Costa Rica’s Catholic Church asks for ‘reflection’ on the Hemp and Cannabis Law

QCOSTARICA - The Catholic Church asked Costa Rica's Government...

67 centenarians have been infected with covid-19, most have already recovered

QCOSTARICA - Since the pandemic began in Costa Rica,...

Police shut down a mega-party of 1,600 people in a warehouse located in La Uruca

QCOSTARICA - The Fuerza Publica (National Police) intervened, this...

Vehicle restrictions start at 12 am from today

QCOSTARICA - Starting today,  Monday, January 24, the vehicle...

Costa Rican firm will convert passenger planes to alleviate cargo demand

QCOSTARICA - Costa Rican talent will, starting in March,...

Facebook experiments with Costa Rica reducing political content

QCOSTARICA - Meta, the multinational technology conglomerate, is carrying...
Paying the bills

Share

The American pharmaceutical giant Pfizer and its German partner BioNTech announced that a third dose of their coronavirus jab offers strong protection against the omicron variant, according to initial study results published Wednesday.

Lab tests revealed a 25-fold increase in antibody levels, the firm said. However, the news came with the caveat that the initial two doses of the vaccine may not be enough to prevent infection with the highly transmissable variant.

“Although two doses of the vaccine may still offer protection against severe disease caused by the Omicron strain, it’s clear from these preliminary data that protection is maximized with a third dose of our vaccine,” Pfizer CEO Albert Bourla said in a statement.

- Advertisement -

Blood samples taken a month after a booster showed people harbored levels of omicron-neutralizing antibodies that were similar to amounts proven protective against earlier variants after two doses.

Pfizer’s study still needs to undergo scientific review, but it marks the first concrete information from a vaccine manufacturer about booster effectiveness and the omicron variant.

There is still much that is unknown about omicron, but it has been detected in 57 countries and is thought to be behind an uptick in cases in the United States and several European countries.

 

- Advertisement -
Paying the bills
Q Costa Rica
Reports by QCR staff

Related Articles

67 centenarians have been infected with covid-19, most have already recovered

QCOSTARICA - Since the pandemic began in Costa Rica, in March...

Police shut down a mega-party of 1,600 people in a warehouse located in La Uruca

QCOSTARICA - The Fuerza Publica (National Police) intervened, this Saturday, at...

Subscribe to our stories

To be updated with all the latest news, offers and special announcements.

Log In

Forgot password?

Forgot password?

Enter your account data and we will send you a link to reset your password.

Your password reset link appears to be invalid or expired.

Log in

Privacy Policy

Add to Collection

No Collections

Here you'll find all collections you've created before.